Back to Search
Start Over
Telix Pharmaceuticals submits TLX101-CDx NDA to US FDA
- Source :
- M2 EquityBites (EQB). August 28, 2024
- Publication Year :
- 2024
-
Abstract
- M2 EQUITYBITES-August 28, 2024-Telix Pharmaceuticals submits TLX101-CDx NDA to US FDA (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Telix Pharmaceuticals Limited (ASX: TLX), an Australia-based biopharmaceutical company, announced on Wednesday that it has [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 EquityBites (EQB)
- Publication Type :
- News
- Accession number :
- edsgcl.806365986